Amicus Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
29.09.23
/
50%
€11.70
Target price
29.09.24
€17.92
Performance (%)
-18.80%
Price
25.04.24
€9.50
Summary
This prediction is currently active. The price of Amicus Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.80%. This prediction currently runs until 29.09.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.476% | -0.039% |
| iShares Nasdaq 100 | 1.290% | 0.504% |
| iShares Nikkei 225® | 1.300% | -2.135% |
| iShares S&P 500 | 0.829% | 0.193% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $17.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat